North America held a dominant market position, capturing more than a 38.2% share, holding USD 14.37 billion in revenue.
Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced ...
Abstract: Several applications, such as text-to-SQL and computational fact checking, exploit the relationship between relational data and natural language text. However, state of the art solutions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback